CARVYKTI® (ciltacabtagene autoleucel) logo
  • About CARVYKTI®
    How CARVYKTI® works
    Manufacturing CARVYKTI®
  • Cartitude-4 Efficacy
    Primary Analysis
    Study Design
    Progression-Free Survival (PFS)
    Overall Survival (OS)
    Depth of Response
    Duration of Response
    Follow-Up Analysis
    Progression-Free Survival (PFS)
    Overall Survival (OS)
    Depth of Response
    Duration of Response
  • CARVYKTI® Safety
    Boxed Warning
    Cytokine Release
    Syndrome (CRS)
    Neurologic Toxicities
    Hemophagocytic
    Lymphohistiocytosis (HLH)
    Prolonged and/or
    Recurrent Cytopenias
    Secondary Malignancies
    Additional Warnings & Precautions, and ARs ≥10%
    Long-Term Safety
  • TREATMENT PROCESS
    Patient Eligibility
    Steps in the Treatment Process
  • Resources
    For Physicians
    For Nurses/APPs
    For Patients/Care Partners
    Patient Support Program
    For Access and Reimbursement Support
    For Order Management
  • Additional Trials
    Cartitude-1 Efficacy
    Study Design
    Depth of Response
    Duration of Response
    Survival Rates
    Time to Response
  • Unmet Need
  • Treatment Centers
  • Coverage Lookup
  • Get In Touch
  • CARVYKTI® Prescribing Information
  • CARVYKTI® REMS
  • Contact Us
  • Go To Patient Website
  • Prescribing Information
    CARVYKTI® PRESCRIBING INFORMATION
    CARVYKTI® LA INFORMACIÓN DE PRESCRIPCIÓN
  • CARVYKTI® REMS
  • Get In Touch
  • Contact Us
  • For US Healthcare Professionals
  • Go To Patient Website
Treatment CentersCoverage Lookup

Contact Us

Medical Information Center

Thank you for your interest in contacting Janssen Biotech, Inc. Please note that we can only provide information about products marketed within the United States, and must refer international inquiries to our affiliates.

If you require immediate assistance or wish to report a side effect or product complaint, Janssen Medical Information can be reached by phone at 1-800-JANSSEN (1-800-526-7736), Monday - Friday 9:00 AM to 8:00 PM Eastern Time.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For additional information, please contact Janssen Medical Information by using one of the following methods:

Phone: Call 1-800-JANSSEN (1-800-526-7736), Monday – Friday, 9:00 AM to 8:00 PM Eastern Time.

Email: Submit questions via our askjanssenmedinfo.com site.

Mail: If you prefer to correspond with us via regular mail, or have inquiries regarding vendor opportunities or marketing/product suggestions, please use the following address:

Janssen Scientific Affairs Medical Information Center
PO Box 200
Titusville, NJ 08560

Search:
JanssenMD Logo

For CQUENCE® Order Management Fulfillment Support

VISIT CQUENCEPORTAL.com , or CALL 1-833-276-7337 (1-833-CQORDER) , Monday – Friday, 8:00 AM to 8:00 PM Eastern Time.

For MyCARVYKTI® Patient Support Services

To get your patients started, contact a MyCARVYKTI® patient support specialist at 1-800-559-7875, Monday – Friday, 8:00 AM to 8:00 PM Eastern Time.

For Risk Evaluation and Mitigation Strategy (REMS)

If you have questions regarding the Risk Evaluation and Mitigation Strategy (REMS), please contact Janssen Biotech, Inc., by visiting www.CARVYKTIrems.com or at 1-844-672-0067, Monday – Friday, 8:00 AM to 8:00 PM Eastern Time.

GET IN
TOUCH

Questions? Ask to be Contacted by a CARVYKTI® Representative

CONTACT A REP

SCROLL TO TOP ↑